+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Organs-on-chips Market Research Report by Type, Application, End-user, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4857886
  • Report
  • October 2021
  • Region: Global
  • 192 Pages
  • 360iResearch™
UP TO OFF
until Jan 01st 2022
Global Organs-on-chips Market is Projected to Reach USD 115.78 Million by 2026, Registering a CAGR of 33.41%

FEATURED COMPANIES

  • AxoSim, Inc
  • CN Bio Innovations
  • HµREL Corporation
  • Kirkstall Ltd.
  • Nortis
  • SynVivo, Inc
The Global Organs-on-chips Market size was estimated at USD 20.53 million in 2020, is expected to reach USD 27.32 million in 2021, and projected to grow at a CAGR of 33.41% reaching USD 115.78 million by 2026.



Market Statistics


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage


This research report categorizes the Organs-on-chips to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Type, the market was studied across Artery-on-a-chip, Brain-on-a-chip, Heart-on-a-chip, Kidney-on-a-chip, Lung-on-a-chip, and Skin-on-a-chip.
  • Based on Application, the market was studied across Drug Discovery, Physiological Model Development, and Toxicology Research.
  • Based on End-user, the market was studied across Academic & Research Institutes, Cosmetics Industry, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The analyst's ongoing research amplifies their research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Organs-on-chips Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Organs-on-chips Market, including AxoSim, Inc, BioIVT, CN Bio Innovations, Emulate, Inc., HemoShear Therapeutics, LLC, HµREL Corporation, InSphero AG, Kirkstall Ltd., Mimetas, Nortis, Organovo, Inc., SynVivo, Inc, Tara Biosystems, and TissUse GmbH.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Organs-on-chips Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Organs-on-chips Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Organs-on-chips Market?
4. What is the competitive strategic window for opportunities in the Global Organs-on-chips Market?
5. What are the technology trends and regulatory frameworks in the Global Organs-on-chips Market?
6. What is the market share of the leading vendors in the Global Organs-on-chips Market?
7. What modes and strategic moves are considered suitable for entering the Global Organs-on-chips Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AxoSim, Inc
  • CN Bio Innovations
  • HµREL Corporation
  • Kirkstall Ltd.
  • Nortis
  • SynVivo, Inc
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Increasing focus on developing alternatives for animal testing models
5.2.2. Significant increase in research funding and venture capital investments for the development of organs-on-chips
5.2.3. Technological advancements and new products launches
5.2.4. Growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers
5.2.5. Rising need for early detection of drug toxicity to minimize financial losses due to late-stage drug failure
5.2.6. Growing initiatives to increase awareness about organs-on-chips technologies
5.3. Restraints
5.3.1. Issues related to the incorporation of organs-on-chips technologies into existing workflows
5.4. Opportunities
5.4.1. Growing focus on drug discovery activities
5.4.2. Application of organs-on-chips in oncology research
5.4.3. Development of multiple-organs-on-a-chip models
5.5. Challenges
5.5.1. Complexity of organs-on-chips models
5.5.2. Dearth of skilled professionals

6. Organs-on-chips Market, by Type
6.1. Introduction
6.2. Artery-on-a-chip
6.3. Brain-on-a-chip
6.4. Heart-on-a-chip
6.5. Kidney-on-a-chip
6.6. Lung-on-a-chip
6.7. Skin-on-a-chip

7. Organs-on-chips Market, by Application
7.1. Introduction
7.2. Drug Discovery
7.3. Physiological Model Development
7.4. Toxicology Research

8. Organs-on-chips Market, by End-user
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Cosmetics Industry
8.4. Pharmaceutical & Biotechnology Companies

9. Americas Organs-on-chips Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Organs-on-chips Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Organs-on-chips Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, by Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. AxoSim, Inc.
13.2. BioIVT
13.3. CN Bio Innovations
13.4. Emulate, Inc.
13.5. HemoShear Therapeutics, LLC
13.6. HµREL Corporation
13.7. InSphero AG
13.8. Kirkstall Ltd.
13.9. Mimetas
13.10. Nortis
13.11. Organovo, Inc.
13.12. SynVivo, Inc.
13.13. Tara Biosystems
13.14. TissUse GmbH

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
Figure 1. Global Organs-On-Chips Market Size, 2020 vs 2026 (USD Million)
Figure 2. Global Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 3. Global Organs-On-Chips Market: Market Dynamics
Figure 4. Global Organs-On-Chips Market Size, by Type, 2020 vs 2026 (%)
Figure 5. Global Organs-On-Chips Market Size, by Type, 2020 vs 2026 (USD Million)
Figure 6. Competitive Strategic Window for Global Organs-On-Chips Market Size, by Type, 2026
Figure 7. Global Organs-On-Chips Market Size, by Artery-On-A-Chip, 2018-2026 (USD Million)
Figure 8. Global Organs-On-Chips Market Size, by Artery-On-A-Chip, by Region, 2020 vs 2026 (USD Million)
Figure 9. Global Organs-On-Chips Market Size, by Brain-On-A-Chip, 2018-2026 (USD Million)
Figure 10. Global Organs-On-Chips Market Size, by Brain-On-A-Chip, by Region, 2020 vs 2026 (USD Million)
Figure 11. Global Organs-On-Chips Market Size, by Heart-On-A-Chip, 2018-2026 (USD Million)
Figure 12. Global Organs-On-Chips Market Size, by Heart-On-A-Chip, by Region, 2020 vs 2026 (USD Million)
Figure 13. Global Organs-On-Chips Market Size, by Kidney-On-A-Chip, 2018-2026 (USD Million)
Figure 14. Global Organs-On-Chips Market Size, by Kidney-On-A-Chip, by Region, 2020 vs 2026 (USD Million)
Figure 15. Global Organs-On-Chips Market Size, by Lung-On-A-Chip, 2018-2026 (USD Million)
Figure 16. Global Organs-On-Chips Market Size, by Lung-On-A-Chip, by Region, 2020 vs 2026 (USD Million)
Figure 17. Global Organs-On-Chips Market Size, by Skin-On-A-Chip, 2018-2026 (USD Million)
Figure 18. Global Organs-On-Chips Market Size, by Skin-On-A-Chip, by Region, 2020 vs 2026 (USD Million)
Figure 19. Global Organs-On-Chips Market Size, by Application, 2020 vs 2026 (%)
Figure 20. Global Organs-On-Chips Market Size, by Application, 2020 vs 2026 (USD Million)
Figure 21. Competitive Strategic Window for Global Organs-On-Chips Market Size, by Application, 2026
Figure 22. Global Organs-On-Chips Market Size, by Drug Discovery, 2018-2026 (USD Million)
Figure 23. Global Organs-On-Chips Market Size, by Drug Discovery, by Region, 2020 vs 2026 (USD Million)
Figure 24. Global Organs-On-Chips Market Size, by Physiological Model Development, 2018-2026 (USD Million)
Figure 25. Global Organs-On-Chips Market Size, by Physiological Model Development, by Region, 2020 vs 2026 (USD Million)
Figure 26. Global Organs-On-Chips Market Size, by Toxicology Research, 2018-2026 (USD Million)
Figure 27. Global Organs-On-Chips Market Size, by Toxicology Research, by Region, 2020 vs 2026 (USD Million)
Figure 28. Global Organs-On-Chips Market Size, by End-user, 2020 vs 2026 (%)
Figure 29. Global Organs-On-Chips Market Size, by End-user, 2020 vs 2026 (USD Million)
Figure 30. Competitive Strategic Window for Global Organs-On-Chips Market Size, by End-user, 2026
Figure 31. Global Organs-On-Chips Market Size, by Academic & Research Institutes, 2018-2026 (USD Million)
Figure 32. Global Organs-On-Chips Market Size, by Academic & Research Institutes, by Region, 2020 vs 2026 (USD Million)
Figure 33. Global Organs-On-Chips Market Size, by Cosmetics Industry, 2018-2026 (USD Million)
Figure 34. Global Organs-On-Chips Market Size, by Cosmetics Industry, by Region, 2020 vs 2026 (USD Million)
Figure 35. Global Organs-On-Chips Market Size, by Pharmaceutical & Biotechnology Companies, 2018-2026 (USD Million)
Figure 36. Global Organs-On-Chips Market Size, by Pharmaceutical & Biotechnology Companies, by Region, 2020 vs 2026 (USD Million)
Figure 37. Americas Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 38. Argentina Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 39. Brazil Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 40. Canada Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 41. Mexico Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 42. United States Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 43. Asia-Pacific Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 44. Australia Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 45. China Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 46. India Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 47. Indonesia Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 48. Japan Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 49. Malaysia Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 50. Philippines Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 51. Singapore Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 52. South Korea Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 53. Taiwan Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 54. Thailand Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 55. Europe, Middle East & Africa Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 56. France Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 57. Germany Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 58. Italy Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 59. Netherlands Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 60. Qatar Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 61. Russia Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 62. Saudi Arabia Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 63. South Africa Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 64. Spain Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 65. United Arab Emirates Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 66. United Kingdom Organs-On-Chips Market Size, 2018-2026 (USD Million)
Figure 67. Global Organs-On-Chips Market: FPNV Positioning Matrix
Figure 68. Global Organs-On-Chips Market: Share, by Key Player, 2020
Figure 69. Competitive Scenario Analysis in Global Organs-On-Chips Market, by Type

List of Tables
Table 1. Global Organs-On-Chips Market: Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016–2020
Table 3. Global Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 4. Global Organs-On-Chips Market Size, by Type, 2018-2026 (USD Million)
Table 5. Global Organs-On-Chips Market Size, by Artery-On-A-Chip, by Region, 2018-2026 (USD Million)
Table 6. Global Organs-On-Chips Market Size, by Brain-On-A-Chip, by Region, 2018-2026 (USD Million)
Table 7. Global Organs-On-Chips Market Size, by Heart-On-A-Chip, by Region, 2018-2026 (USD Million)
Table 8. Global Organs-On-Chips Market Size, by Kidney-On-A-Chip, by Region, 2018-2026 (USD Million)
Table 9. Global Organs-On-Chips Market Size, by Lung-On-A-Chip, by Region, 2018-2026 (USD Million)
Table 10. Global Organs-On-Chips Market Size, by Skin-On-A-Chip, by Region, 2018-2026 (USD Million)
Table 11. Global Organs-On-Chips Market Size, by Application, 2018-2026 (USD Million)
Table 12. Global Organs-On-Chips Market Size, by Drug Discovery, by Region, 2018-2026 (USD Million)
Table 13. Global Organs-On-Chips Market Size, by Physiological Model Development, by Region, 2018-2026 (USD Million)
Table 14. Global Organs-On-Chips Market Size, by Toxicology Research, by Region, 2018-2026 (USD Million)
Table 15. Global Organs-On-Chips Market Size, by End-user, 2018-2026 (USD Million)
Table 16. Global Organs-On-Chips Market Size, by Academic & Research Institutes, by Region, 2018-2026 (USD Million)
Table 17. Global Organs-On-Chips Market Size, by Cosmetics Industry, by Region, 2018-2026 (USD Million)
Table 18. Global Organs-On-Chips Market Size, by Pharmaceutical & Biotechnology Companies, by Region, 2018-2026 (USD Million)
Table 19. Americas Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 20. Argentina Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 21. Brazil Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 22. Canada Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 23. Mexico Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 24. United States Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 25. Asia-Pacific Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 26. Australia Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 27. China Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 28. India Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 29. Indonesia Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 30. Japan Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 31. Malaysia Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 32. Philippines Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 33. Singapore Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 34. South Korea Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 35. Taiwan Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 36. Thailand Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 37. Europe, Middle East & Africa Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 38. France Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 39. Germany Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 40. Italy Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 41. Netherlands Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 42. Qatar Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 43. Russia Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 44. Saudi Arabia Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 45. South Africa Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 46. Spain Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 47. United Arab Emirates Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 48. United Kingdom Organs-On-Chips Market Size, 2018-2026 (USD Million)
Table 49. Global Organs-On-Chips Market: Scores
Table 50. Global Organs-On-Chips Market: Business Strategy
Table 51. Global Organs-On-Chips Market: Product Satisfaction
Table 52. Global Organs-On-Chips Market: Ranking
Table 53. Global Organs-On-Chips Market: Share, by Key Player, 2020
Table 54. Global Organs-On-Chips Market: Merger & Acquisition
Table 55. Global Organs-On-Chips Market: Agreement, Collaboration & Partnership
Table 56. Global Organs-On-Chips Market: New Product Launch & Enhancement
Table 57. Global Organs-On-Chips Market: Investment & Funding
Table 58. Global Organs-On-Chips Market: Award, Recognition & Expansion
Table 59. Global Organs-On-Chips Market: License & Pricing
Note: Product cover images may vary from those shown
  • AxoSim, Inc
  • BioIVT
  • CN Bio Innovations
  • Emulate, Inc.
  • HemoShear Therapeutics, LLC
  • HµREL Corporation
  • InSphero AG
  • Kirkstall Ltd.
  • Mimetas
  • Nortis
  • Organovo, Inc.
  • SynVivo, Inc
  • Tara Biosystems
  • TissUse GmbH
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll